USA Overview

Compugen USA, Inc. is a wholly-owned subsidiary of Compugen USA, Ltd. Located in South San Francisco, California, Compugen Inc.'s mission is to translate our growing portfolio of novel oncology and immunology targets into promising monoclonal antibody (mAb) therapeutics for licensing and partnering. Compugen's novel mAb targets are generated utilizing its unique Monoclonal Antibody Targets Discovery Platform, which delivers high quality therapeutic candidates to address unmet medical needs.